| 缩写名/全名 |
ASSAY DRUG DEV TECHN
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES |
||||||||||||||||||||
| ISSN号 | 1540-658X | ||||||||||||||||||||
| 研究方向 | 医学-生化研究方法 | ||||||||||||||||||||
| 影响因子 | 2015:1.655, 2016:2.196, 2017:1.593, 2018:1.42, 2019:1.187, | ||||||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 26 | ||||||||||||||||||||
| 出版年份 | 2002 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | >12周，或约稿 |
||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||
| 投稿链接 | http://www.liebertpub.com/forauthors/assay-and-drug-development-technologies/118/ | ||||||||||||||||||||
| 投稿官网 | http://www.liebertpub.com/overview/assay-and-drug-development-technologies/118/ | ||||||||||||||||||||
| h-index | 52 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1540-658X%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Closantel Suppresses Angiogenesis and Cancer Growth in Zebrafish Models Author: chunqili Journal: ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2016. |
| 2. | A cell-based assay for screening spindle checkpoint inhibitors. Author: Wu ZH, Hu LY, Xu da Q, Li X. Journal: Assay Drug Dev Technol. 2012 Aug;10(4):344-52. doi: 10.1089/adt.2011.416. Epub 2012 Feb 21. PubMed |
| 3. | Preparation and activity analysis of recombinant human high-density lipoprotein. Author: Su M, Chang W, Shi K, Wang D, Wang M, Xu T, Yan W. Journal: Assay Drug Dev Technol. 2012 Oct;10(5):485-91. doi: 10.1089/adt.2012.467. Epub 2012 Aug 16. PubMed |
|
|
